Literature DB >> 12734357

Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.

Valérie Dutoit1, Philippe Guillaume, Maha Ayyoub, Charles S Hesdorffer, Immanuel F Luescher, Danila Valmori.   

Abstract

The CD8 coreceptor plays a crucial role in both T cell development in the thymus and in the activation of mature T cells in response to Ag-specific stimulation. In this study we used soluble peptides-MHC class I (pMHC) multimeric complexes bearing mutations in the CD8 binding site that impair their binding to the MHC, together with altered peptide ligands, to assess the impact of CD8 on pMHC binding to the TCR. Our data support a model in which CD8 promotes the binding of TCR to pMHC. However, once the pMHC/TCR complex is formed, the TCR dominates the pMHC/TCR dissociation rates. As a consequence of these molecular interactions, under physiologic conditions CD8 plays a key role in complex formation, resulting in the enhancement of CD8 T cell functions whose specificity, however, is determined by the TCR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12734357     DOI: 10.4049/jimmunol.170.10.5110

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Bi-specific MHC heterodimers for characterization of cross-reactive T cells.

Authors:  Zu T Shen; Michael A Brehm; Keith A Daniels; Alexander B Sigalov; Liisa K Selin; Raymond M Welsh; Lawrence J Stern
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

2.  CD8 kinetically promotes ligand binding to the T-cell antigen receptor.

Authors:  Dmitry M Gakamsky; Immanuel F Luescher; Aladdin Pramanik; Ronen B Kopito; François Lemonnier; Horst Vogel; Rudolf Rigler; Israel Pecht
Journal:  Biophys J       Date:  2005-06-24       Impact factor: 4.033

3.  Modulation of MHC binding by lateral association of TCR and coreceptor.

Authors:  Karlo Perica; Joan Glick Bieler; Michael Edidin; Jonathan Schneck
Journal:  Biophys J       Date:  2012-11-07       Impact factor: 4.033

4.  The impact of TCR-binding properties and antigen presentation format on T cell responsiveness.

Authors:  Adam S Chervin; Jennifer D Stone; Phillip D Holler; Ailin Bai; Jianzhu Chen; Herman N Eisen; David M Kranz
Journal:  J Immunol       Date:  2009-06-24       Impact factor: 5.422

5.  Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface.

Authors:  Linda Wooldridge; Hugo A van den Berg; Meir Glick; Emma Gostick; Bruno Laugel; Sarah L Hutchinson; Anita Milicic; Jason M Brenchley; Daniel C Douek; David A Price; Andrew K Sewell
Journal:  J Biol Chem       Date:  2005-04-18       Impact factor: 5.157

6.  Analysis, Isolation, and Activation of Antigen-Specific CD4(+) and CD8(+) T Cells by Soluble MHC-Peptide Complexes.

Authors:  Julien Schmidt; Danijel Dojcinovic; Philippe Guillaume; Immanuel Luescher
Journal:  Front Immunol       Date:  2013-07-30       Impact factor: 7.561

7.  Identification of new MUC1 epitopes using HLA-transgenic animals: implication for immunomonitoring.

Authors:  Tanja Scheikl-Gatard; Caroline Tosch; François Lemonnier; Ronald Rooke
Journal:  J Transl Med       Date:  2017-07-05       Impact factor: 5.531

8.  Cytomegalovirus-Specific CD8+ T-Cells With Different T-Cell Receptor Affinities Segregate T-Cell Phenotypes and Correlate With Chronic Graft-Versus-Host Disease in Patients Post-Hematopoietic Stem Cell Transplantation.

Authors:  Thomas Poiret; Rebecca Axelsson-Robertson; Mats Remberger; Xiao-Hua Luo; Martin Rao; Anurupa Nagchowdhury; Anna Von Landenberg; Ingemar Ernberg; Olle Ringden; Markus Maeurer
Journal:  Front Immunol       Date:  2018-04-10       Impact factor: 7.561

9.  CD8 Co-Receptor Enhances T-Cell Activation without Any Effect on Initial Attachment.

Authors:  Philippe Robert; Laurent Limozin; P Anton van der Merwe; Pierre Bongrand
Journal:  Cells       Date:  2021-02-18       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.